People: Keryx Biopharmaceuticals Inc (KERX.PH)

KERX.PH on Philadelphia Stock Exchange

8.07USD
11:42am EDT
Price Change (% chg)

$0.13 (+1.64%)
Prev Close
$7.94
Open
$8.13
Day's High
$8.19
Day's Low
$7.88
Volume
8,087
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

Tarnok, Michael 

Brief Biography

Mr. Michael P. Tarnok serves as Independent Chairman of the Board of Keryx Biopharmaceuticals Inc. He has served on Board of Directors since September 2007, and as Chairman of the Board since June 2009. Mr. Tarnok served as interim chief executive officer from April 2009 to May 2009. A seasoned finance and operational executive, Mr. Tarnok joined the Board with pharmaceutical industry experience in a wide range of functional areas. Mr. Tarnok spent the majority of his career at Pfizer Inc., which he joined in 1989 as Finance Director — US Manufacturing, and from 2000 – 2007, served as Senior Vice President, Finance in Pfizer’s U.S. Pharmaceuticals Division. In this position, Mr. Tarnok handled all finance responsibilities for the division, including contracting, trade management, forecasting of product launches and Sarbanes-Oxley compliance. Prior to joining Pfizer, Mr. Tarnok worked primarily in financial disciplines for ITT Rayonier, Inc., Celanese Corporation and Olivetti Corporation of America. Mr. Tarnok earned an M.B.A. in Marketing from New York University and B.S. in Accounting from St. John’s University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
72,500 -- 6,621 130,121

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Michael Tarnok

130,121

Ron Bentsur

887,428

James Oliviero

616,109

Amit Sharma

--

Kevin Cameron

--

Joseph Feczko

--
As Of 30 Dec 2011
Search Stocks